Psychometrics of patient-reported bother from side effects of treatment single-items in industry-sponsored oncology trials

被引：0
|
作者：
Peter C. Trask
Tracy Holt
Timothy Pearman
机构：
[1] Genentech,
[2] PAREXEL International,undefined
[3] Supportive Oncology,undefined
[4] Robert H. Lurie Comprehensive Cancer Center of Northwestern University,undefined
[5] School of Medicine,undefined
来源：
Quality of Life Research | 2023年 / 32卷
关键词：
Quality of life; Oncology; Single item measure; Symptom bother; Clinical trials;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2601 / 2615
页数：14
相关论文
共 50 条
  • [1] Psychometrics of patient-reported bother from side effects of treatment single-items in industry-sponsored oncology trials
    Trask, Peter C.
    Holt, Tracy
    Pearman, Timothy
    QUALITY OF LIFE RESEARCH, 2023, 32 (09) : 2601 - 2615
  • [2] Current status of patient-reported outcomes in industry-sponsored oncology clinical trials and product labels
    Gondek, Kathleen
    Sagnier, Pierre-Philippe
    Gilchrist, Kim
    Woolley, J. Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (32) : 5087 - 5093
  • [3] Patient-Reported Outcomes in Metastatic Breast Cancer: A Review of Industry-Sponsored Clinical Trials
    Krohe, Meaghan
    Hao, Yanni
    Lamoureux, Roger E.
    Galipeau, Nina
    Globe, Denise
    Foley, Catherine
    Mazar, Iyar
    Solomon, Jeffrey
    Shields, Alan L.
    BREAST CANCER-BASIC AND CLINICAL RESEARCH, 2016, 10 : 93 - 102
  • [4] Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events: Methods for item selection in industry-sponsored oncology clinical trials
    Trask, Peter C.
    Dueck, Amylou C.
    Piault, Elisabeth
    Campbell, Alicyn
    CLINICAL TRIALS, 2018, 15 (06) : 616 - 623
  • [5] Assessment of Patient-Reported Outcomes in Industry-Sponsored Phase I Oncology Studies: Considerations for Translating Theory Into Practice
    Gnanasakthy, Ari
    Norcross, Lindsey
    Fitzgerald, Kristina
    VALUE IN HEALTH, 2023, 26 (10) : 1440 - 1443
  • [6] Validity and utility of a single-item measure of patient-reported bother from side effects of cancer therapy
    Pearman, Timothy
    Beaumont, Jennifer
    Mroczek, Daniel
    O'Connor, Mary
    Globe, Denise
    Cella, David
    PSYCHO-ONCOLOGY, 2018, 27 : 38 - 38
  • [7] Validity and Usefulness of a Single-Item Measure of Patient-Reported Bother From Side Effects of Cancer Therapy
    Pearman, Timothy P.
    Beaumont, Jennifer L.
    Mroczek, Daniel
    O'Connor, Mary
    Cella, David
    CANCER, 2018, 124 (05) : 991 - 997
  • [8] Exploration of baseline patient-reported side effect bother from cancer therapy
    Roydhouse, Jessica K.
    King-Kallimanis, Bellinda L.
    Roy, Pourab
    Weinstock, Chana
    Krol, Danielle
    Daniels, Selena R.
    Suzman, Daniel L.
    Beaver, Julia A.
    Kluetz, Paul G.
    CLINICAL TRIALS, 2020, 17 (03) : 332 - 337
  • [9] Relationship between patient-reported bother from side effects, adverse events and survival in advanced ovarian cancer
    Wenzel, Lari
    Osann, Kathryn
    Cella, David
    Fulci, Giulia
    Birrer, Michael
    QUALITY OF LIFE RESEARCH, 2018, 27 : S45 - S46
  • [10] Low and moderate grade adverse events are important contributors to patient-reported treatment side-effect bother
    O'Connell, Nathaniel
    Zhao, Fengmin
    Lee, Ju-Whei
    Hong, Fanxgin
    Shen, Shu-En
    Ip, Edward
    Salem, Winston
    Peipert, John
    Graham, Noah
    Smith, Mary Lou
    Gareen, Llana
    Carlos, Ruth
    Obeng-Gyasi, Samilia
    Miller, Kathy
    Partridge, Ann
    Shanafelt, Tait
    Sparano, Joseph
    Stewart, Keith
    Tarhini, Ahmad
    Thomas, Mary
    Weiss, Matthias
    Cella, David
    Wagner, Lynne
    Gray, Robert
    QUALITY OF LIFE RESEARCH, 2021, 30 (SUPPL 1) : S82 - S82
12345